Bedlington Terriers are a beloved breed among American dog enthusiasts, but they are known to be predisposed to copper toxicosis, a serious hereditary liver disorder. Also known as COMMD1 disease, it causes excessive copper to accumulate in the liver, triggering inflammation and damage that can lead to liver failure and death if left untreated.
Copper is a vital trace mineral necessary in small amounts for a dog’s healthy metabolism and bodily functions. The liver regulates copper balance by filtering out excess copper and excreting it through bile. However, in copper toxicosis, a genetic mutation disrupts this regulation.
This condition stems from a mutation in the COMMD1 gene, which impairs the liver's ability to eliminate copper effectively. As copper accumulates within liver cells, toxic levels develop, leading to chronic hepatitis and progressive scarring called cirrhosis. Symptoms usually emerge slowly, becoming evident around age three or later.
While primarily affecting Bedlington Terriers, crossbreed dogs with Bedlington ancestry in the U.S. can also inherit this mutation. Thanks to genetic testing and selective breeding programs utilized within American breeding communities, the occurrence of this disease has notably decreased over the years.
The gene defect follows an autosomal recessive inheritance pattern. This means a dog must inherit two faulty gene copies, one from each parent, to develop copper toxicosis. Dogs with only one copy are carriers without symptoms but can pass the gene to offspring.
The symptoms typically appear as liver damage advances. Signs pet owners should look for include:
Because these symptoms develop gradually, early genetic screening is key to managing and preventing serious outcomes.
In the United States, veterinarians and breeders commonly use the COMMD1 genetic deletion test, which detects carriers, affected dogs, and those free from the mutation. Samples for this DNA test are obtained by cheek swabs or blood draws and analyzed by accredited laboratories, with results returned within one to two weeks.
American breeders rely on these test results to make informed mating choices—avoiding breeding two carriers or two affected dogs—to reduce disease frequency responsibly while preserving the breed’s genetic diversity.
If you're considering a Bedlington Terrier puppy from American breeders, always ask for clear proof of COMMD1 genetic testing for both parents. Supporting breeders committed to health screening helps curtail this inherited condition in the breed.
Although there is no cure for the genetic defect, U.S. veterinary care emphasizes early detection, monitoring, and medical management. Treatment often includes copper chelation therapy using medications like D-penicillamine and zinc supplementation to reduce hepatic copper and protect liver function. Regular liver enzyme tests and ultrasounds help track disease progression.
Veterinarians also recommend feeding low-copper diets and administering supportive supplements such as milk thistle antioxidants or other liver protectants to improve quality and length of life.
Routine veterinary follow-up remains essential to catch symptoms promptly and adjust treatment plans.
Copper toxicosis in Bedlington Terriers is a serious inherited liver disorder caused by a mutation in the COMMD1 gene affecting copper metabolism. Genuine understanding of its genetic inheritance, vigilant symptom awareness, and routine genetic testing are vital for responsible ownership and breeding within the U.S.
As an owner or breeder, consulting with your veterinarian about DNA testing through programs from organizations like the American Kennel Club (AKC) or university veterinary genetics labs is recommended. Always request health clearances when acquiring puppies to support breed welfare and reduce disease transmission.
Remember: Responsible breeding and early genetic screening are essential steps to safeguard future generations of this distinctive breed from the impacts of copper toxicosis.